Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL)
Hisashi Hidaka, Namiki Izumi, Takeshi Aramaki, Masafumi Ikeda, Yoshitaka Inaba, Kazuho Imanaka, Takuji Okusaka, Susumu Kanazawa, Shuichi Kaneko, Shinichi Kora, Hiroya Saito, Junji Furuse, Osamu Matsui, Tatsuya Yamashita, Osamu Yokosuka, Satoshi Morita, Hitoshi Arioka, Masatoshi Kudo, Yasuaki Arai (2019). Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL). , 36(6), DOI: https://doi.org/10.1007/s12032-019-1272-2.
Article15 days agoErratum: Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
Masatoshi Kudo, Osamu Matsui, Namiki Izumi, M Kadoya, Takuji Okusaka, Shiro Miyayama, Koichiro Yamakado, Kazuhiro Tsuchiya, Kazuomi Ueshima, Atsushi Hiraoka (2017). Erratum: Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update. , DOI: https://doi.org/10.6084/m9.figshare.5241700.
Corrigendum15 days agoReport of the 19th follow‐up survey of primary liver cancer in Japan
Masatoshi Kudo, Namiki Izumi, Takafumi Ichida, Yonson Ku, Norihiro Kokudo, Michiie Sakamoto, Tadatoshi Takayama, Osamu Nakashima, Osamu Matsui, Yutaka Matsuyama (2016). Report of the 19th follow‐up survey of primary liver cancer in Japan. , 46(5), DOI: https://doi.org/10.1111/hepr.12697.
Article15 days agoSurvival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis
Satoshi Kitai, Masatoshi Kudo, Naoshi Nishida, Namiki Izumi, Michiie Sakamoto, Yutaka Matsuyama, Takafumi Ichida, Osamu Nakashima, Osamu Matsui, Yonson Ku, Norihiro Kokudo, Masatoshi Makuuchi (2016). Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis. , 5(3), DOI: https://doi.org/10.1159/000367765.
Article15 days agoSurvival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan
Masatoshi Kudo, Namiki Izumi, Michiie Sakamoto, Yutaka Matsuyama, Takafumi Ichida, Osamu Nakashima, Osamu Matsui, Yonson Ku, Norihiro Kokudo, Masatoshi Makuuchi (2016). Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan. , 5(3), DOI: https://doi.org/10.1159/000367775.
Article15 days ago